Logos ofNama Chemicals Co. and Saudi Industrial Export Co. (Sadirat)
Nama Chemicals Co. and Saudi Industrial Export Co. (Sadirat) announced that a binding subscription agreement was signed today between Nama Chemicals, Jubail Chemical Industries Co. (Jana) one of its subsidiaries and FAAD Partners Financial Co. (FAAD Partners), licensed by the Capital Market Authority under license number 32-23270. 
Under this agreement, FAAD Partners will inject SAR 200 million into Jana in exchange for acquiring a 40% stake in Jana’s capital through the issuance of new shares to Fad Partners.
For more news and details on MAs
The general assembly approved on March 24, 2025 the acquisition offer submitted by FAAD Partners to acquire 40% of Jana for SAR 200 million, a non-binding offer, in accordance with the agreed terms and conditions.
Additionally, the assembly authorized the board of directors to complete the transaction procedures, negotiate the final terms, sign the necessary agreements and contracts, and take all legal, accounting, and regulatory actions required to complete the transaction in the best interest of the company and its shareholders.
It is expected that the financial impact will be reflected in the second half of 2025.
The two companies said, in separate statements, that they will announce any developments in this regard as soon as they become available.
According to Argaam’s data, Nama Chemicals and Sadirat announced in February that FAAD Partners Co.’s non-binding offer to Nama Chemicals was approved. The SAR 200 million offer is aimed at acquiring 40% of Jubail Chemical Industries Co. (JANA), a subsidiary of Nama Chemicals, through the issuance of new shares.
In October 2024, Sadirat’s subsidiary, Haddaj Investment Co., entered into a non-binding agreement in October 2024 with FAAD to establish an investment fund aimed at acquiring a stake in JANA.
Logos ofNama Chemicals Co. and Saudi Industrial Export Co. (Sadirat)
Nama Chemicals Co. and Saudi Industrial Export Co. (Sadirat) announced that a binding subscription agreement was signed today between Nama Chemicals, Jubail Chemical Industries Co. (Jana) one of its subsidiaries and FAAD Partners Financial Co. (FAAD Partners), licensed by the Capital Market Authority under license number 32-23270.
Under this agreement, FAAD Partners will inject SAR 200 million into Jana in exchange for acquiring a 40% stake in Jana’s capital through the issuance of new shares to Fad Partners.
For more news and details on MAs
The general assembly approved on March 24, 2025 the acquisition offer submitted by FAAD Partners to acquire 40% of Jana for SAR 200 million, a non-binding offer, in accordance with the agreed terms and conditions.
Additionally, the assembly authorized the board of directors to complete the transaction procedures, negotiate the final terms, sign the necessary agreements and contracts, and take all legal, accounting, and regulatory actions required to complete the transaction in the best interest of the company and its shareholders.
It is expected that the financial impact will be reflected in the second half of 2025.
The two companies said, in separate statements, that they will announce any developments in this regard as soon as they become available.
According to Argaam’s data, Nama Chemicals and Sadirat announced in February that FAAD Partners Co.’s non-binding offer to Nama Chemicals was approved. The SAR 200 million offer is aimed at acquiring 40% of Jubail Chemical Industries Co. (JANA), a subsidiary of Nama Chemicals, through the issuance of new shares.
In October 2024, Sadirat’s subsidiary, Haddaj Investment Co., entered into a non-binding agreement in October 2024 with FAAD to establish an investment fund aimed at acquiring a stake in JANA.
